Cargando…

Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry

An analytical method for the quantitative measurement of ML-7, a product with possible anti-immune escape activity for feline infectious peritonitis virus (FIPV), in feline plasma was developed and validated. The sample preparation consists of a solid-phase extraction step on an MCX cartridge. ML-7...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherlet, Marc, Gleich, Sabine, Dewerchin, Hannah, Nauwynck, Hans, Daminet, Sylvie, De Backer, Patrick, Croubels, Siska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105240/
https://www.ncbi.nlm.nih.gov/pubmed/22925719
http://dx.doi.org/10.1016/j.jchromb.2012.08.014
_version_ 1783512366868070400
author Cherlet, Marc
Gleich, Sabine
Dewerchin, Hannah
Nauwynck, Hans
Daminet, Sylvie
De Backer, Patrick
Croubels, Siska
author_facet Cherlet, Marc
Gleich, Sabine
Dewerchin, Hannah
Nauwynck, Hans
Daminet, Sylvie
De Backer, Patrick
Croubels, Siska
author_sort Cherlet, Marc
collection PubMed
description An analytical method for the quantitative measurement of ML-7, a product with possible anti-immune escape activity for feline infectious peritonitis virus (FIPV), in feline plasma was developed and validated. The sample preparation consists of a solid-phase extraction step on an MCX cartridge. ML-7 and ML-9, used as the internal standard for the analysis, were separated on an ACQUITY UPLC™ BEH C(18) reversed-phase column (1.7 μm, 50 mm × 2.1 mm I.D.), using isocratic elution with acetonitrile and 0.1% formic acid in water as the mobile phase. Both compounds were subsequently quantified in MRM mode on a Micromass(®) Quattro Premier™ XE triple quadrupole mass spectrometer. The use of a Thermo Scientific(®) Exactive™ orbitrap mass spectrometer made it possible to confirm the proposed fragmentation pattern of both ML-7 and ML-9. A validation study according to EC requirements was carried out, in which the method showed good performance. Linear behaviour was observed in the 1–2500 ng ml(−1) range, which is relevant for real sample analysis. Accuracy and precision were within the criteria requested by the EC requirements throughout this concentration range. Extraction recovery of ML-7 was 72%. Matrix effect for ML-7 was not higher than 8%. The method was successfully used for the monitoring of ML-7 in feline plasma after intravenous, subcutaneous or oral administration of an ML-7 formulation, for the determination of pharmacokinetic parameters, with a limit of quantification of 1 ng ml(−1) and a limit of detection of 0.4 ng ml(−1). The proposed method also shows good characteristics for the analysis of ML-7 in plasma of other animal species and human plasma.
format Online
Article
Text
id pubmed-7105240
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71052402020-03-31 Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry Cherlet, Marc Gleich, Sabine Dewerchin, Hannah Nauwynck, Hans Daminet, Sylvie De Backer, Patrick Croubels, Siska J Chromatogr B Analyt Technol Biomed Life Sci Article An analytical method for the quantitative measurement of ML-7, a product with possible anti-immune escape activity for feline infectious peritonitis virus (FIPV), in feline plasma was developed and validated. The sample preparation consists of a solid-phase extraction step on an MCX cartridge. ML-7 and ML-9, used as the internal standard for the analysis, were separated on an ACQUITY UPLC™ BEH C(18) reversed-phase column (1.7 μm, 50 mm × 2.1 mm I.D.), using isocratic elution with acetonitrile and 0.1% formic acid in water as the mobile phase. Both compounds were subsequently quantified in MRM mode on a Micromass(®) Quattro Premier™ XE triple quadrupole mass spectrometer. The use of a Thermo Scientific(®) Exactive™ orbitrap mass spectrometer made it possible to confirm the proposed fragmentation pattern of both ML-7 and ML-9. A validation study according to EC requirements was carried out, in which the method showed good performance. Linear behaviour was observed in the 1–2500 ng ml(−1) range, which is relevant for real sample analysis. Accuracy and precision were within the criteria requested by the EC requirements throughout this concentration range. Extraction recovery of ML-7 was 72%. Matrix effect for ML-7 was not higher than 8%. The method was successfully used for the monitoring of ML-7 in feline plasma after intravenous, subcutaneous or oral administration of an ML-7 formulation, for the determination of pharmacokinetic parameters, with a limit of quantification of 1 ng ml(−1) and a limit of detection of 0.4 ng ml(−1). The proposed method also shows good characteristics for the analysis of ML-7 in plasma of other animal species and human plasma. Elsevier B.V. 2012-09-15 2012-08-14 /pmc/articles/PMC7105240/ /pubmed/22925719 http://dx.doi.org/10.1016/j.jchromb.2012.08.014 Text en Copyright © 2012 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cherlet, Marc
Gleich, Sabine
Dewerchin, Hannah
Nauwynck, Hans
Daminet, Sylvie
De Backer, Patrick
Croubels, Siska
Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
title Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
title_full Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
title_fullStr Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
title_full_unstemmed Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
title_short Quantitative analysis of an anti-viral immune escape compound ML-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
title_sort quantitative analysis of an anti-viral immune escape compound ml-7 in feline plasma using ultra performance liquid chromatography/electrospray ionization mass spectrometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105240/
https://www.ncbi.nlm.nih.gov/pubmed/22925719
http://dx.doi.org/10.1016/j.jchromb.2012.08.014
work_keys_str_mv AT cherletmarc quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry
AT gleichsabine quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry
AT dewerchinhannah quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry
AT nauwynckhans quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry
AT daminetsylvie quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry
AT debackerpatrick quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry
AT croubelssiska quantitativeanalysisofanantiviralimmuneescapecompoundml7infelineplasmausingultraperformanceliquidchromatographyelectrosprayionizationmassspectrometry